Skip to main content

Paediatric drug use with focus on

Buy Article:

$51.00 plus tax (Refund Policy)



Aim:  To perform a nationwide investigation of paediatric drug use at Swedish hospitals, including an analysis of off‐label drug use.

Methods:  All paediatric hospitals in Sweden were invited to register all prescriptions to children, aged between 0 and 18, during two separate 2‐day‐periods in 2008. Data were reported and analysed with respect to licence status and proportion of and reasons for off‐label drug use.

Results:  Data on 11 294 prescriptions to 2947 paediatric patients were received. Drugs associated with pain relief, infection, prematurity, nutrition and surgery or anaesthesia were most commonly used. Paracetamol was the most frequently used drug on‐label and also among the most commonly used off‐label drugs. Nearly half (49%) of all administered prescriptions concerned unlicensed drugs, off‐label drugs or extemporaneously prepared drugs. The corresponding rate among neonates was 69%. Lack of paediatric information in the Summary of Product Characteristics was the main reason for off‐label classification.

Conclusions:  Paediatric off‐label drug use is common at Swedish hospitals, and nearly half of all prescriptions were not documented for use in children. The findings emphasize a need for paediatric clinical studies as well as compilation of existing clinical experience and scattered evidence, particularly for drug treatment in infants and neonates.

Document Type: Research Article


Affiliations: 1: Astrid Lindgrens Childrens Hospital, Neonatal Unit, Karolinska University Hospital, Stockholm, Sweden 2: Medical Products Agency, Uppsala, Sweden 3: Department of Clinical Sciences, Intervention and Technology (CLINTEC), Division of Paediatrics, Astrid Lindgrens Children’ s Hospital, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Publication date: July 1, 2012

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more